PIG-W inhibitors are a class of compounds that specifically target the phosphatidylinositol glycan anchor biosynthesis class W (PIG-W) enzyme, which plays a crucial role in the glycosylphosphatidylinositol (GPI) anchor biosynthesis pathway. PIG-W is involved in the addition of a fourth mannose molecule to the growing GPI precursor, a key step in the synthesis of GPI anchors. These anchors are important glycolipid structures that tether various proteins to the cell membrane. By inhibiting PIG-W, researchers can disrupt the formation of functional GPI-anchored proteins, which are involved in various biological processes such as cell signaling, adhesion, and immune recognition. This inhibition allows researchers to investigate the role of GPI-anchored proteins and their importance in maintaining cellular function.
In experimental contexts, PIG-W inhibitors are valuable tools for studying the broader impact of GPI anchor deficiency on cellular processes. By blocking PIG-W activity, researchers can observe the downstream effects on proteins that rely on GPI anchoring for proper localization and function. This can shed light on how cells respond to disruptions in membrane protein attachment and how such disruptions affect cellular communication and signaling pathways. PIG-W inhibitors also allow for the exploration of the molecular mechanisms governing GPI biosynthesis and provide insight into how alterations in this pathway can influence other cellular systems. Through the use of these inhibitors, researchers gain a deeper understanding of the critical role PIG-W plays in cell biology, particularly in the context of GPI anchor-dependent processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Manumycin A | 52665-74-4 | sc-200857 sc-200857A | 1 mg 5 mg | $219.00 $634.00 | 5 | |
Inhibits the isoprenoid biosynthesis enzyme farnesyltransferase, potentially affecting the lipid modification necessary for GPI anchor synthesis. | ||||||
Tunicamycin | 11089-65-9 | sc-3506A sc-3506 | 5 mg 10 mg | $172.00 $305.00 | 66 | |
Blocks N-linked glycosylation, which may indirectly impair the initial glycosylation steps crucial for GPI anchor assembly. | ||||||
Decylubiquinone | 55486-00-5 | sc-358659 sc-358659A | 10 mg 50 mg | $70.00 $269.00 | 10 | |
Inhibits mitochondrial electron transport, which could reduce the cellular resources necessary for GPI anchor biosynthesis. | ||||||
Brefeldin A | 20350-15-6 | sc-200861C sc-200861 sc-200861A sc-200861B | 1 mg 5 mg 25 mg 100 mg | $31.00 $53.00 $124.00 $374.00 | 25 | |
Disrupts Golgi apparatus structure, potentially impairing GPI anchor processing and maturation that occurs in the Golgi. | ||||||
1,1-Dimethylbiguanide, Hydrochloride | 1115-70-4 | sc-202000F sc-202000A sc-202000B sc-202000C sc-202000D sc-202000E sc-202000 | 10 mg 5 g 10 g 50 g 100 g 250 g 1 g | $20.00 $43.00 $63.00 $156.00 $260.00 $510.00 $31.00 | 37 | |
Affects metabolic pathways and may indirectly alter cellular energy states, influencing GPI anchor synthesis. | ||||||
Cerulenin (synthetic) | 17397-89-6 | sc-200827 sc-200827A sc-200827B | 5 mg 10 mg 50 mg | $161.00 $312.00 $1210.00 | 9 | |
Inhibits fatty acid synthase, potentially affecting the glycerolipid synthesis that is a precursor for the GPI anchor. | ||||||
Tipifarnib | 192185-72-1 | sc-364637 | 10 mg | $720.00 | ||
A farnesyltransferase inhibitor, which may affect the prenylation step essential for GPI anchor biosynthesis. | ||||||
Castanospermine | 79831-76-8 | sc-201358 sc-201358A | 100 mg 500 mg | $184.00 $632.00 | 10 | |
Inhibits glucosidase I and II, enzymes involved in the trimming of GPI anchor carbohydrate residues. | ||||||
N-Butyldeoxynojirimycin·HCl | 210110-90-0 | sc-201398 sc-201398A sc-201398B | 5 mg 25 mg 50 mg | $180.00 $550.00 $985.00 | 4 | |
Inhibits glucosylceramide synthase, which could influence the availability of glycolipids for GPI anchor synthesis. | ||||||